StandPoint Health Research
StandPoint Health Research helps you bring therapies to market- faster & smarter
End-to-end support for early development and regulatory execution in pharmaceuticals, biotech, and natural health products.
From submission strategy to vendor qualification and compliant documentation; we bring clarity and control to complex workflows.
Our Core Services
Regulatory Strategy & Submissions
• IND, NDA, ANDA, 510(k), PMA, NPN planning
• Regulatory pathway selection & health authority communications
• Licensing support (DIN, NPN, DEL/Site, NNHPD, provincial)
Scientific & Regulatory Writing
• Submission-ready dossiers & NPN applications
• Clinical protocols, investigator brochures, SOPs
• Compliance reviews, gap analysis, and audits
Vendor Identification & Oversight
• CRO, CDMO, and lab selection & qualification
• GMP/NHP-compliant vendor management
• Contract negotiation & risk oversight
Operational Support
• SOP development & validation
• Trial readiness & documentation
• Early-stage operational compliance
Therapeutic Areas Supported
Oncology | Cardiovascular | CNS | Dermatology | Endocrinology | Women’s Health | Arthritis | Fatty Liver Disease
Therapeutic Modalities
Small Molecules | Biologics | Advanced Therapies | Vaccines | Drug–Device Combos | Topicals | Digital & RNA Therapeutics | Cell & Gene Therapies | Genome Editing | Controlled Substances/Cannabinoids
Principal Consultant
Dr. Rashmi Tiwari, Ph.D., CCRP, is a regulatory affairs expert and vendor management specialist supporting early-stage biopharma companies. She navigates FDA and Health Canada pathways, CDSA and Cannabis Act compliance, clinical trial applications, GxP systems, and quality standards, delivering strategic, efficient execution across U.S. and Canadian markets. With 15+ years of experience spanning academia, pharma, and CROs, she brings both scientific depth and operational precision. Her expertise extends across oncology, endocrinology, women’s health, CNS, and advanced delivery technologies, with proven strength in controlled-substance programs. She partners with innovators to transform regulatory complexity into clear, compliant, and timely development solutions.
Thank you,
Rashmi Tiwari, PhD, CCRP
Founder | Principal Consultant
| Email: rtiwari@standpointhealth.com
www.standpointhealth.com | linkedin.com/in/rashmitiwari-phd-ccrp
Related

REGMEDICAL Inc.
REGMEDICAL provides New Drug Submission (NDS) package preparation and submission, sNDS submissions, pre-NDS meetings/negotiations with Health Canada, Product Monograph...
October 7, 2025

ClaroPV Services Inc.
ClaroPV offers comprehensive and proficient support for pre-approval and post-market Pharmacovigilance (PV) and Medical Information (MI) services across various categories of...
September 23, 2025

Intrinsik Corp.
As a recognized leader in the industry, our team of experts provide regulatory and scientific advice to help you identify the most efficient drug development and registration...
September 19, 2025